Water-dispersed gold nanoparticles (AuNPs-H) and gold nanoparticles in the presence of surfactants cetyltrimethylammonium bromide (AuNPs-CTAB) and didecyldimethylammonium bromide (AuNPs-C10DAB) were synthesized and characterized using several techniques. The differences in the UV-Vis spectral profiles of these nanoparticles were studied monitoring the intensity and the localized surface plasmon resonance band (LSPR) maximum wavelength; these were monitored as a function of time taking into account storage conditions: under refrigeration (4 Celsius degrees) and at room-temperature (27 Celsius degrees). Anomalous (more unstable) profile was observed for AuNPs-C10DAB at 1.0 × 10-4 mol L-1. Their catalytic activities were also evaluated in the presence of 4-nitrophenol and it was shown that the most effective kinetics was observed for the system without surfactant. Finally, an interaction study with aminoglycosides (AMG) was conducted aiming the application of nanoparticles as analytical probe. Only AuNPs-H produced adequate results, indicating that the surfactant prevents interaction between AMG and the surface of the nanoparticles since at higher concentrations of CTAB or C10DAB there is no significant variation in the original probe signal in presence of AMG. An analytical method was developed based on the AuNPs-H-gentamicin and AuNPs-H-neomycin interaction taking into consideration the optimization of the parameters: AuNPs-H concentration, buffer, signal stabilization time and the AMG concentration range. In the adjusted condition for quantitative probing, each dispersion consisted of 40 percent v/v (1.2 × 10-9 mol L-1) of AuNPs-H, 1.0 mL of citrate buffer pH 4.0 (1.0 × 10-2 mol L-1) and final volume of 5.0 mL adjusted with ultrapure water addition, after appropriate micro-volumes of a stock solution of AMG (except in blank dispersion) or sample added. The spectral profiles were monitored at 511 and 681 nm, allowing theconstruction of analytical curves at 681, and at the ratio (681/511). For gentamicin, the linear range reached from 0.6 to 600 microgram L-1 with the limit of detection (LD) of 0.06 microgram L-1 . For neomycin, the linear range was 7.3 to 550 microgram L-1, with LD of 6.2 microgram L-1. The application of the method was made by determining gentamicin(fortification) in whole milk, and neomycin in control solution (simulated aqueous sample), pharmaceutical samples and saliva. In order to enable selectivity of the method it was necessary to use solid phase extraction (SPE) using a commercial SPE cartridge packed with an AMG molecular imprinted polymer. In milk samples (40 microlitre), after clean up and SPE, it was possible to quantify 1,72 plus-minus 0,03 microgram gentamicin, which is equivalent to 39,1 plus-minus 0,2 percent). Recoveries for neomycin in drug samples were approximately 45 plus-minus 3.0 percent (after SPE), indicating interferences of other components. Neomycin was also recovered in saliva samples after drug use obtaining values close to 0.36 plus-minus 0.02 microgram. In contrast, the recoveries in simulated samples reached up to 102.6 plus-minus 1.3 percent (no need for SPE). Finally, a comparative evaluation of the interaction of AuNPs-H and gold nanoparticles synthesized with reduction with citrate (AuNPs-citrato) was performed, indicating differences in terms of the interaction with AMG.